Detalhe da pesquisa
1.
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med
; 21(3): e1004360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502656
2.
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Lancet
; 399(10337): 1779-1789, 2022 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35378077
3.
Population-Level Correlation Between Incidence of Curable Sexually Transmitted Infections and Human Immunodeficiency Virus (HIV)-1 Among African Women Participating in HIV-1 Pre-Exposure Prophylaxis Trials.
J Infect Dis
; 226(6): 1069-1074, 2022 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35763413
4.
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
J Infect Dis
; 225(10): 1741-1749, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301540
5.
The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence.
AIDS Behav
; 25(12): 4169-4179, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939034
6.
Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region.
J Glob Health
; 13: 06020, 2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352144
7.
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
Lancet HIV
; 8(2): e87-e95, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539762